Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
DENTSPLY Sirona Inc (NASDAQ: XRAY) closed the day trading at $17.26 down -28.02% from the previous closing price of $23.98. In other words, the price has decreased by -$28.02 from its previous closing price. On the day, 29.89 million shares were traded. XRAY stock price reached its highest trading level at $20.01 during the session, while it also had its lowest trading level at $17.22.
Ratios:
For a better understanding of XRAY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.54 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.61. For the most recent quarter (mrq), Quick Ratio is recorded 0.87 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 0.72 whereas as Long-Term Debt/Eq ratio is at 0.60.
On October 25, 2024, Needham reiterated its Buy rating and also upped its target price recommendation from $34 to $29.
Needham reiterated its Buy rating for the stock on August 20, 2024, and also maintained the target price at $34.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 08 ’24 when LUCIER GREGORY T bought 8,212 shares for $24.35 per share. The transaction valued at 199,983 led to the insider holds 66,661 shares of the business.
LUCIER GREGORY T bought 3,577 shares of XRAY for $99,976 on May 31 ’24. The Director now owns 58,374 shares after completing the transaction at $27.95 per share. On Nov 22 ’23, another insider, LUCIER GREGORY T, who serves as the Director of the company, bought 10,000 shares for $31.44 each. As a result, the insider paid 314,400 and bolstered with 43,121 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XRAY now has a Market Capitalization of 4863108608 and an Enterprise Value of 6816080384. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.90 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 1.75 whereas that against EBITDA is 11.137.
Stock Price History:
Over the past 52 weeks, XRAY has reached a high of $37.60, while it has fallen to a 52-week low of $22.84. The 50-Day Moving Average of the stock is -30.47%, while the 200-Day Moving Average is calculated to be -38.61%.
Shares Statistics:
Over the past 3-months, XRAY traded about 2.45M shares per day on average, while over the past 10 days, XRAY traded about 2762870 shares per day. A total of 207.20M shares are outstanding, with a floating share count of 201.13M. Insiders hold about 0.78% of the company’s shares, while institutions hold 105.60% stake in the company. Shares short for XRAY as of 1728950400 were 16350203 with a Short Ratio of 6.66, compared to 1726185600 on 17167482. Therefore, it implies a Short% of Shares Outstanding of 16350203 and a Short% of Float of 9.25.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 1.22.
Earnings Estimates
Investors are keenly observing as 9.0 analysts analyze and rate the current performance of DENTSPLY Sirona Inc (XRAY) in the stock market.The consensus estimate for the next quarter is $0.59, with high estimates of $0.63 and low estimates of $0.54.
Analysts are recommending an EPS of between $2.03 and $1.93 for the fiscal current year, implying an average EPS of $1.98. EPS for the following year is $2.28, with 15.0 analysts recommending between $2.43 and $2.15.
Revenue Estimates
12 analysts predict $939.1M in revenue for the current quarter. It ranges from a high estimate of $951.39M to a low estimate of $928.04M. As of the current estimate, DENTSPLY Sirona Inc’s year-ago sales were $947MFor the next quarter, 12 analysts are estimating revenue of $1B. There is a high estimate of $1.03B for the next quarter, whereas the lowest estimate is $940.48M.
A total of 14 analysts have provided revenue estimates for XRAY’s current fiscal year. The highest revenue estimate was $3.91B, while the lowest revenue estimate was $3.83B, resulting in an average revenue estimate of $3.88B. In the same quarter a year ago, actual revenue was $3.96BBased on 14 analysts’ estimates, the company’s revenue will be $3.99B in the next fiscal year. The high estimate is $4.05B and the low estimate is $3.82B.
